Health Care

-- Generic drugmaker Sanofi (NASDAQ: SNY) reported net income of EUR 1.77 billion or EUR 1.49 per share for the third quarter,

Celgene (CELG) Q3 profit jumps 56% beats estimates

Celgene Corporation (NASDAQ: CELG) reported a 56% jump in earnings for the third quarter of 2019 helped by higher revenue as well

Abiomed’s (ABMD) revenue increases 13% in Q2 on higher usage of Impella; reiterates 2020 outlook

Abiomed (NASDAQ: ABMD) reported a 13% growth in second quarter 2020 revenue, boosted by the increased usage of its Impella heart pumps.

Bristol-Myers Squibb (BMY) earnings: Q3 results beat amid strong product sales

Driven by the strong sales of leading products, earnings of Bristol-Myers Squibb (NYSE: BMY) increased in the third quarter and exceeded the

Cigna (NYSE: CI): Q3 2019 Earnings Snapshot

-- Cigna Corporation (NYSE: CI) reported its third-quarter 2019 adjusted operating earnings of $4.54 per share versus $4.36 per share expected. --

ACADIA Pharmaceuticals (ACAD): Q3 2019 Earnings Snapshot

-- ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) reported Q3 2019 loss of $0.29 per share, vs. $0.40 expected. -- Revenues grew 62% to

Vertex Pharmaceuticals (VRTX): Q3 2019 Earnings Snapshot

-- Vertex Pharmaceuticals (NASDAQ: VRTX) reported third-quarter 2019 earnings of $1.23 per share, vs. $1.15 per share expected -- Total revenue grew

Bristol-Myers (BMY) Q3 earnings preview: New indications, pipeline to bolster recovery

Bristol-Myers Squibb (NYSE: BMY) will be publishing its September-quarter earnings Thursday before the opening bell. The bio-pharmaceutical company is expected to earn

McKesson Corporation (MCK): Q3 2019 Earnings Snapshot

-- McKesson Corporation (NYSE: MCK) reported third-quarter 2019 earnings of $3.60 per share, in line with the street projection. -- Total revenue

Stryker (SYK): Q3 2019 Earnings Snapshot

-- Stryker (NYSE: SYK) reported third-quarter 2019 earnings of $1.91 per share, vs. $1.90 per share expected. -- Total revenue grew 10.6%

Amgen beats in Q3, raises guidance

Amgen Inc (NASDAQ: AMGN) reported third-quarter 2019 adjusted EPS of $3.66 on revenue of $5.74 billion. This was better than analysts’ prediction

Pfizer (PFE) reports better-than-expected Q3 results; stock gains

Drugmaker Pfizer (NYSE: PFE) reported lower revenues and earnings for the third quarter. The results, however, topped the market's expectations. The management

Merck’s (MRK) Q3 results beat estimates; sales boosted by oncology and vaccines

Merck (NYSE: MRK) surpassed analysts’ expectations for revenue and earnings in the third quarter of 2019, sending the shares climbing 2.5% in

Walgreens Boots (WBA) earnings preview: No surprises expected in Q4 report

October 25, 2019March 30, 2020

It has been a tough year for Walgreens Boots Alliance (NASDAQ: WBA) so far, with the stock losing steadily amid muted sales

Gilead Sciences, Inc (GILD): Q3 2019 Earnings Snapshot

-- Gilead Sciences (NYSE: GILD) reported third-quarter 2019 earnings of $1.75 per share, vs. $1.74 per share expected. -- Total revenue remained

Baxter International Inc. (BAX) Q3 2019 Earnings Snapshot

-- Baxter International Inc. (NYSE: BAX) reported third-quarter 2019 revenues of $2.85 billion, up 3% YoY, vs. $2.86 billion expected. -- Operating

GNC Holdings (GNC) Q3 2019 Earnings Snapshot

-- GNC Holdings (NYSE: GNC) reported an adjusted loss per share of $0.02 for the third quarter of 2019 compared to an

AstraZeneca (NYSE: AZN): Q3 2019 Earnings Snapshot